Sho Iwaki

6PUBLICATIONS
14CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Instruments and techniquesCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 31, 2026
Biomarker-Driven Initial Systemic Therapy Enabling Curative-Intent Treatment in Non-Metastatic Unresectable Salivary Duct Carcinoma: A Multi-Institutional Retrospective Study.

|May 04, 2026
Association of Underweight, Sarcopenia, and Cancer Cachexia with Survival Outcomes in Hypopharyngeal Cancer Radiotherapy.

|May 19, 2025
Conversion Surgery After Administration of a TRK Inhibitor for Unresectable Parotid Gland Secretory Carcinoma.

Arisa Nagano, Takuma Matoba, Daisuke Kawakita

|Apr 01, 2025
Clinical Outcomes of Intensity Modulated Proton Therapy for Salivary Gland Carcinoma: High Local Control and Quality of Life Preservation.

Gaku Takano, Daisuke Kawakita, Hiromitsu Iwata

|Apr 30, 2024
Comprehensive genomic profiling of salivary gland carcinoma: Analysis of the Center for Cancer Genomics and Advanced Therapeutics database in Japan.

Sho Iwaki, Daisuke Kawakita, Toshitaka Nagao

|Jan 17, 2024
Impact of salvage chemotherapy after immune checkpoint inhibitor for recurrent or metastatic head and neck cancer.

Takuma Matoba, Kiyoshi Minohara, Daisuke Kawakita

Pageof 1

Frequent Collaborators

4 joint publications

Takuma Matoba

2 joint publications

Yuichiro Tada

1 joint publications

Daisuke Kawakita

1 joint publications

Yoshitaka Honma